ARCHIVES

PR firm Ketchum serves two clients on Medicare issues: CMS and ASCO. HHS policy officials weren’t told about potential conflict, department spokesman says.

This article is from The Cancer Letter archive.

Vol. 30 No. 36 | September 24, 2004

Download PDF Visit The Full Archive

Related Articles

ASCO Annual Report Names Significant Clinical Research Advances Of Past Year

December 25, 2009

New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet,

January 19, 2007

Tobacco Council awards $10 Million In 1986

August 14, 1987

Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic

May 30, 2014

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

March 1, 2002

DCT Board Pediatric Phase 1 Studies, Effort to Assess Obstacles To Clinical Trials

July 6, 1984